Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -41.63% is 96% above its 2-year average of -1047.05%, near the high end of its 2-year range (-5725.24%–-34.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 97.27% above its 12-month average of -1523.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -41.63%.
RETURN ON INVESTED CAPITAL (ROIC)
-41.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1523.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+97.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.29%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
-47.16%
vs the sector median at left
Anteris Technologies Global Corp.
Market Cap
$734.10M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-1523.45%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$719.64M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$749.55M
Return on Invested Capital (ROIC)
-36.83%
TTM Avg
-41.75%
3Y Avg
-59.42%
5Y Avg
-51.49%
Market Cap
$709.33M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
9.98%
3Y Avg
8.97%
5Y Avg
8.63%
Market Cap
$707.86M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
Market Cap
$767.46M
Return on Invested Capital (ROIC)
-19.45%
TTM Avg
-59.05%
3Y Avg
-125.75%
5Y Avg
-106.53%
Market Cap
$698.60M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$774.32M
Return on Invested Capital (ROIC)
-42.83%
TTM Avg
-51.53%
3Y Avg
-51.53%
5Y Avg
-51.53%
Market Cap
$775.72M
Return on Invested Capital (ROIC)
-38.92%
TTM Avg
-31.45%
3Y Avg
-27.82%
5Y Avg
-24.27%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $734.10M | -41.63% | -1523.45% | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | N/A | -136.50% | -154.74% | -122.58% |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | -36.83% | -41.75% | -59.42% | -51.49% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | 6.11% | 9.98% | 8.97% | 8.63% |
| Helus Pharma Inc. (HELP)vs › | $707.86M | -73.27% | -60.64% | -63.77% | -62.42% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | -19.45% | -59.05% | -125.75% | -106.53% |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | -110.62% | -99.41% | -74.42% | -73.36% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | -42.83% | -51.53% | -51.53% | -51.53% |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | -38.92% | -31.45% | -27.82% | -24.27% |
| Geron Corporation (GERN)vs › | $776.24M | -8.34% | -22.82% | -51.67% | -50.32% |
ROIC
-41.6%
ROE
-41.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -41.63% |
| 2026-03-31 | -34.04% |
| 2025-12-31 | -5725.24% |
| 2025-09-30 | -1498.37% |
| 2025-06-30 | -317.96% |
| 2025-03-31 | -185.55% |
| 2024-12-31 | -124.11% |
| 2024-09-30 | -1270.79% |
| 2024-06-30 | -1218.33% |
| 2024-03-31 | -822.02% |
| 2023-12-31 | -279.48% |
